Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.65
0.00 (0.00%)
Feb 25, 2026, 2:11 PM EST - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 10.59M | 8.08M | 8.61M | 3.64M | - | |
| 30.99% | -6.14% | 136.79% | - | - | |
| 10.59M | 8.08M | 8.61M | 3.64M | - | |
| 30.99% | -6.14% | 136.79% | - | - | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 10.59M | 8.08M | 8.61M | 3.64M | - | |
| 30.99% | -6.14% | 136.79% | - | - | |
| 10.59M | 8.08M | 8.61M | 3.64M | - | |
| 30.99% | -6.14% | 136.79% | - | - | |
Source: S&P Global Market Intelligence.
